13.11 Summary
For many health care consumers, on-demand screening in the primary care clinic saves weeks or months of waiting for an appointment at an eye care facility for a traditional physician-provided dilated eye examination; indeed, for some, digital imaging is their first experience obtaining ophthalmic health care. For those patients found to have vision-threatening disease, digital screening brings them one step closer to obtaining the expert ophthalmic treatment they require to preserve their vision and to remain productive members of society.
We believe that every patient screening encounter represents an improvement in health care delivery. Each screening can overcome racial, ethnic and economic disparities. Each contributes to equity of care. Each is a victory over apathy, ignorance, and lack of access to high quality health care — barriers that far too often lead to blindness for people with diabetes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289(1):76–79
National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (2004) National diabetes fact sheet. http://www.cdc.gov/diabetes/pubs/estimates.htm. Cited 3 Feb 2004
US Department of Health and Human Services, Agency for Healthcare Research and Quality (2003) National Healthcare Disparities Report 2003. http://qualitytools.ahrq.gov/disparitiesReport/ download_report.aspx. Cited 3 June 2004
Saadine JB, Narayan KMV, Vinicor F (2003) Vision loss: a public health problem? Ophthalmology 110(2):253–254
Verma L, Prakash G, Tewari HK (2002) Diabetic retinopathy: time for action. No complacency please! Lett Bull World Health Organ 80(5):419
Centers for Disease Control and Prevention (2002) Socioeconomic status of women with diabetes — United States, 2000. MMWR Morb Mortal Wkly Rep 51:147–148, 159
Munoz B, West SK, Rubin GS, et al. (2000) Causes of blindness and visual impairment in a population of older Americans: the Salisbury Eye Evaluation Study. Arch Ophthalmol 118:819–825
West SK, Klein R, Rodriguez J, Munoz B, Broman AT, Sanchez R, Snyder R (2001) Diabetes and diabetic retinopathy in a Mexican-American population. Diabetes Care 24:1204–1209
Bonds DE, Zaccaro DJ, Karter AJ, Selby JV, Saad M, Goff DC (2003) Ethnic and racial differences in diabetes care: the Insulin Resistance Atherosclerosis Study. Diabetes Care 26:1040–1046
Villalpando CG, Villalpando EG, Diaz SM, Martinez DR, Perez BA, Andrade SI, Stern MP (1997) A diabetic retinopathy screening program as a strategy for blindness prevention. Arch Med Res 28(1):129–135
National Health Service, National Screening Committee. Preservation of sight in diabetes: a risk reduction program. http://www.diabetic-retinopathy. screening.nhs.uk/diabetic-retinopathy.html. Cited 4 Feb 2004
Cummins E, Facey K, Macpherson K, Morris A, Reay L, Slattery J (2001) Health technology assessment of organization of services for diabetic retinopathy screening. Health Technology Board for Scotland, Glasgow
Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110(9):1677–1682
Wilson JMG, Jungner G (1968) Principles and practice of screening for disease; public health paper number 34. World Health Organization, Geneva
James M, Turner DA, Broadbent DM, Vora J, Harding SP (2000) Cost-effectiveness analysis of screening for sight threatening diabetic eye disease. Br Med J 320:1627–1631
Merin LM, Reeves D (2003) Technical issues in retinopathy screening (letter). Diabetes Care 26(3):965–966
Patel KH, Javitt JC, Tielsch JM, Street DA, Katz J, Quigley HA, Sommer A (1995) Incidence of acute angle-closure glaucoma after pharmacologic mydriasis. Am J Ophthalmol 120(6):709–717
Pandit RJ, Taylor R (2000) Mydriasis and glaucoma: exploding the myth: a systematic review. Diabet Med 17(10):693–699
Broadbent DM, Harding SP, Gillibrand WP, Vora JP (1997) Visual acuity detects CSMO? The value of visual acuity measurement in screening for diabetic maculopathy; the Liverpool Diabetic Eye Study. Diabet Med 14(l1):S65
Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK for EURODIAB IDDM Complications Study Group (1995) Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia 38:437–444
Stellingwerf C, Hardus PLLJ, Hooymans JMM (2001) Two-field photography can identify patients with vision-threatening diabetic retinopathy. Diabetes Care 24:2086–2090
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Merin, L.M. (2006). Digital Detection of Diabetic Retinopathy — Screening From an American Perspective. In: Yogesan, K., Kumar, S., Goldschmidt, L., Cuadros, J. (eds) Teleophthalmology. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-33714-8_13
Download citation
DOI: https://doi.org/10.1007/3-540-33714-8_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-24337-3
Online ISBN: 978-3-540-33714-0
eBook Packages: MedicineMedicine (R0)